Stocks-NEOG-Neogen Corporation

NEOG Neogen Corporation

15.43 0.09 (0.57%)
Market ClosedDelayed Prices By NASDAQ, in USD
Trade
Trade

Overview

Prev Close 15.35
Day's Range 14.78 - 15.49
52 Week Range 11.44 - 21.78
Average Volume (3M) 1.79M
1-Year Return -21.92%
Beta1.0685
Market Cap 3.33B
P/E Ratio-352.87
Revenue924.22M
EPS-0.0435
Dividend (Yield) 0 (0%)
Industry
Medical Specialties
CEO
John E. Adent
Employees
2,917

FINANCIAL SUMMARY

For the fiscal year ended 31/5/2024: Neogen Corporation's revenues increased by 12.37% and amounted to 924.22M. Net income increased by 58.81% to -9.42M. Net assets increased by 0.32% to 3.14B and EPS increased from -0.12 to -0.04.
NEOG's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Created with Highcharts 4.2.7 /Highstock 4.2.7Total RevenueNet Income08/2311/2302/2405/24-50M050M100M150M200M250M
Gross Margin
50.06%
Net Profit Margin
6.52%
Operating Margin
7.50%
Return On Investment
4.02%
08/23
11/23
02/24
05/24
Total Revenue
228.99M
229.63M
228.81M
236.79M
Gross Profit
116.76M
116.77M
116.88M
113.48M
Operating Income
19.14M
14.47M
12.02M
17.57M
Net Income
1.5M
-3.49M
-2.02M
-5.42M